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Abstract 
Background: The Democratic Republic of the Congo (DRC) bears a high burden of malaria, which is exacerbated in 
pregnant women. The VAR2CSA protein plays a crucial role in pregnancy-associated malaria (PAM), and hence quan-
tifying diversity at the var2csa locus in the DRC is important in understanding the basic epidemiology of PAM, and in 
developing a robust vaccine against PAM.
Methods: Samples were taken from the 2013–14 Demographic and Health Survey conducted in the DRC, focusing 
on children under 5 years of age. A short subregion of the var2csa gene was sequenced in 115 spatial clusters, giving 
country-wide estimates of sequence polymorphism and spatial population structure.
Results: Results indicate that var2csa is highly polymorphic, and that diversity is being maintained through balancing 
selection, however, there is no clear signal of phylogenetic or geographic structure to this diversity. Linear modelling 
demonstrates that the number of var2csa variants in a cluster correlates directly with cluster prevalence, but not with 
other epidemiological factors such as urbanicity.
Conclusions: Results suggest that the DRC fits within the global pattern of high var2csa diversity and little genetic 
differentiation between regions. A broad multivalent VAR2CSA vaccine candidate could benefit from targeting stable 
regions and common variants to address the substantial genetic diversity.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Pregnancy-associated malaria (PAM) is a major public 
health concern. In areas of stable malaria transmission 
in sub-Saharan Africa approximately one in four preg-
nant women have evidence of malaria infection at time 
of delivery [1, 2]. PAM is detrimental to both mother and 
child, placing the mother at increased risk of severe anae-
mia whilst increasing the chance of adverse birth out-
comes, including stillbirth, preterm birth and low birth 
weight (LBW) [1–3].
The adverse effects of PAM are mediated by the 
sequestration of infected erythrocytes in the placental 
microvasculature through binding of VAR2CSA—a large 
and genetically diverse parasite protein expressed during 
pregnancy-to human chondroitin sulfate A (CSA) [4, 5]. 
Naturally occurring anti-VAR2CSA antibodies provide 
partial protection against future episodes of PAM, such 
that primigravid women are most susceptible and risk of 
severe infection and LBW decreases in subsequent preg-
nancies [4, 6, 7]. Vaccines against VAR2CSA are currently 
undergoing initial trials [8–10].
Extensive effort has gone into characterizing the par-
ticular sub-region of the VAR2CSA protein responsi-
ble for binding CSA and inducing a protective immune 
response. These efforts have led to the identification 
of ID1-DBL2X; a 1.6  kb segment encoding the minimal 
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binding epitope [11]. ID1-DBL2X has been shown to 
raise antibodies that abrogate the adhesion of infected 
erythrocytes to CSA with the same efficacy and specific-
ity as the full-length extra-cellular protein, while main-
taining high cross-reactivity to multiple parasite lines 
[12]. Both leading PAM vaccine candidates, PlacMalVac 
and PRIMALVAC, use recombinant proteins that target 
overlapping constructs of this region [9, 10].
The ability of any such vaccine to have a sustained 
impact on malaria will depend on the extent of antigenic 
variation in the vaccinated population, which in turn 
depends on the level of sequence polymorphism in the 
var2csa gene. Studies into global diversity at the var2csa 
locus have identified extremely high sequence poly-
morphism, with evidence that diversity is being main-
tained by balancing selection [13–16]. Furthermore, this 
high level of diversity occurs against the backdrop of a 
major dimorphic split in the N-terminal segment of the 
VAR2CSA protein, leading to multiple sequence clusters, 
each of which has been found to associate with a differ-
ent level of parasitaemia [16] and a different risk of poor 
birth outcomes [17]. Sequence polymorphism at the 
var2csa locus is, therefore, both functionally relevant in 
vaccine design and clinically relevant in understanding 
the basic epidemiology of PAM.
The Democratic Republic of Congo (DRC) bears one of 
the highest malaria burdens in sub-Saharan Africa, with 
over 1 million Plasmodium falciparum affected pregnan-
cies each year [18]. Transmission is stable throughout the 
country, and prevalence is estimated at 34.1% on average 
by PCR [19]. The majority of studies into the genetics of 
P. falciparum in DRC have focussed on issues of drug 
resistance (see Additional file 1). Studies into dhps muta-
tions, which confer resistance to sulfadoxine, have found 
distinct geographic clustering of the most highly resist-
ant haplotypes in the east of the country [20, 21]. In con-
trast, countrywide studies into neutral genetic variation 
[22] and variation in the pfama1 gene [23] have found lit-
tle signal of population structure or isolation by distance 
even over large geographic scales. To date, no study has 
explored the geographic and genetic structure of var2csa 
in DRC, and so it is unknown what challenges may lie 
ahead in terms of vaccine design.
This study focused on quantifying genetic variation at 
the var2csa locus in samples obtained from the 2013–14 
Demographic and Health Survey (DHS); a large, cross-
sectional study separated into spatial clusters spanning 
the DRC. Central aims of this study were: (1) to explore 
var2csa diversity in these samples in the context of global 
diversity at this locus, (2) to quantify the level of spatial 
structure in the DRC, and (3) to determine what epide-
miological factors (if any) are predictors of observed 
levels of diversity at this locus. These questions will be 
important for any future interventions aimed at reducing 
PAM in the DRC.
Methods
Sample collection
Samples from children under 5  years of age were col-
lected as part of the 2013–2014 DHS study [19]. Heel- or 
finger-prick blood from each child was used to prepare 
smears for identification of malaria parasites via light 
microscopy, and to prepare dried blood spots (DBS) 
using previously described methods [24]. DBS were 
transported to the University of North Carolina, where 
genomic DNA (gDNA) was extracted using previously 
described methods [25]. Each gDNA sample was tested 
in duplicate in a duplex quantitative real-time PCR assay 
targeting the P. falciparum lactate dehydrogenase gene 
(pfldh) [26] and, as a control, the human β-tubulin gene 
[27]. The full DHS study was conducted in 540 clusters at 
the neighbourhood or village level, and the current study 
was performed on a subset of these clusters. A total of 
115 clusters were selected that contained at least three 
parasitaemic children (i.e. smear and pfldh-positive), and 
that were spatially representative of the whole country 
(Fig. 1). For each of the 115 clusters, all the gDNA sam-
ples were pooled in equimolar volumes to ensure equal 
contribution to the pool of each infected child.
DNA amplification and sequencing
A 400 bp region of the binding domain of VAR2CSA was 
amplified by primers listed in Table 1. Samples from the 
115 clusters were pooled and PCR amplified in techni-
cal duplicates. The forward primer included replicate 
specific molecular identifiers (MIDs) which allowed 
amplicon pooling prior to library preparation using the 
NEBNext Ultra DNA Library Prep Kit for Illumina (New 
England Biolabs, United States). The Illumina primers 
included Illumina’s dual barcoding system. This approach 
enabled multiplexing of pooled samples and libraries into 
one 2 × 300 sequencing run on the Illumina MySeq plat-
form at the University of North Carolina High Through-
put Sequencing Facility.
Haplotype determination
The paired-end sequences were stitched by FLASH 
[28], and haplotype determination was performed using 
the program SeekDeep [29] using a quality cut-off of 
Q30  >  0.75. In brief, sequence reads were first demulti-
plexed according to MIDs into amplicon-specific data, 
resulting in two independent amplicon reads sets for each 
of the 115 pools, after which MIDs were trimmed and 
clustered. Only predicted haplotypes that appeared in 
both replicates for each pool and occurred at a frequency 
of ≥  0.5% were utilized to determine the most likely 
Page 3 of 8Verity et al. Malar J  (2018) 17:46 
haplotypes within each pool. SeekDeep also removed any 
haplotypes that may have resulted from chimerization 
during PCR. This pipeline resulted in the identification of 
583 unique haplotypes throughout the 115 clusters.
Phylogenetic analysis
The similarity between sequences in this study and pre-
viously identified var2csa variants was established by 
conducting a BLAST search of all 583 sequences indi-
vidually against the NCBI database. 81% of top BLAST 
hits came from just two published collections, which 
were downloaded and incorporated, bringing an addi-
tional 84 sequences from Benin [16] and 36 sequences 
from Senegal [30, 31]. The corresponding region of the 
3D7 genome was also downloaded from PlasmoDB [32], 
leading to an expanded data set of 704 sequences. These 
additional sequences were used to improve sequence 
alignment, and to root DRC sequences relative to wider 
African variation.
Initial attempts at multiple sequence alignment 
failed due to difficulties in aligning several highly vari-
able regions containing large numbers of insertions and 
Fig. 1 Result of MAPI analysis. Black circles represent the 115 DHS clusters used in the analysis, grey borders give national and sub-national bounda-
ries, and dark blue regions indicate major water bodies. The colour of each cell represents a weighted average of the pairwise genetic distance 
transecting that cell (white = no data). The two groups of outlined cells in the north have genetic distance that is statistically significant in permuta-
tion testing
Table 1 Primers used
Forward primer Reverse primer
ATCATGGTGGAACACGAACA GTACCCGCTTTACGGTTTCG
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deletions, and so an iterative approach to alignment 
was used. First, all pairwise alignments were produced 
using the msa package in the R programming language 
[33, 34]. Sequences were then grouped into 11 groups 
using agglomerative hierarchical clustering, such that 
sequences with a high proportion of matched bases clus-
tered together. Multiple alignment was then carried out 
on each group independently using the ClustalW algo-
rithm in MEGA7 [35], and any obvious alignment errors 
were removed by hand. Aligned groups were then com-
bined using profile alignment in ClustalX [36]. Regions 
with large numbers of insertions or deletions were iden-
tified by counting the proportion of gaps at each locus, 
and subsequent analyses were restricted to four contigu-
ous regions with zero gaps to ensure that results were not 
influenced by ambiguous alignment in a few highly vari-
able regions (Fig. 2).
A neighbour-joining tree was constructed in MEGA7 
using default substitution parameters, and bootstrapped 
with 100 replicates. Focusing on the 583 sequences from 
DRC hereafter, Tajima’s D statistic was calculated [37] 
and a Z-test for selection was carried out based on rela-
tive rates of synonymous and non-synonymous variation 
in MEGA7 [38].
Spatial and epidemiological analysis
Sequence variants were grouped into the 115 DHS 
clusters from which they derived. The number of clus-
ters occupied by a variant was correlated against the 
top BLAST hit percentage for that variant, to establish 
whether variants that were common in DRC also tended 
to be similar to previously identified sequences. Het-
erozygosity within and between clusters was calculated, 
and nearness to fixation was measured via  GST [39]. Isola-
tion by distance was explored by regressing Nei’s genetic 
distance [40] against geographic distance, and more sub-
tle signals of spatial patterning—for example barriers to 
gene flow—were explored using the program MAPI [41]. 
A matrix of pairwise genetic distances between DHS 
clusters was analysed using MAPI to produce a smoothed 
surface indicating spatial connectivity between regions, 
coupled with a permutation test to identify regions of sig-
nificantly high or low connectivity. MAPI was run using 
default parameters (β = 0.25, eccentricity = 0.975, error 
circle  =  0.1), and statistical significance was assessed 
using 1000 permutations at a threshold of α = 0.05.
Epidemiological analyses focused on finding covariates 
that explained a significant proportion of the observed 
genetic variation through generalized linear modelling 
(GLM). Predictor variables included prevalence of a clus-
ter (defined as the proportion of PCR-positive individu-
als), sample size, and median cycle threshold  (Ct) value; 
 Ct values represent the number of PCR cycles needed 
before a signal is detected in the DNA amplification 
stage, and therefore  Ct is roughly inversely proportional 
to the amount of nucleic acid in the sample. Results of 
the DHS questionnaire for each cluster were also down-
loaded from the DHS website [42], and both “province” 
and “urbanicity” of the cluster (categorized as “large 
city”, “small town” and “countryside”) were included as 
potential predictors. The response variable was the allelic 
richness, defined as the number of unique haplotypes in 
a given cluster. A range of GLMs were considered, start-
ing with a full model containing all the predictors listed 
above and all second-order interaction terms (5  +  25 
terms in total). Backwards stepwise selection was then 
used to identify the model with the lowest Akaike infor-
mation criterion (AIC). This process was repeated for 
both Poisson and negative binomial error structures. A 
separate analysis explored the relationship between  Ct 
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Fig. 2 Schematic of var2csa sequence variation. The proportion of non-gap sequences at each locus (i.e. one minus the proportion of gaps) is plot-
ted for all nucleotide positions relative to Pf3D7 chromosome 12 and corresponding amino-acid positions. The four shaded regions have zero gaps, 
and were used in all analyses after the sequence alignment step. Our sequences mapped to 3D7 positions 54,271:54,663 and amino acid positions 
715:845
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value and prevalence using both a simple linear model 
and a mixed-effects model with cluster modelled as a 
random effect. Mixed effects models do not generate p 
values for individual variables, and so 95% confidence 
intervals for fitted values were obtained by simulation 
using the confint() function in the R package lme4 [43].
Results
Phylogenetic analysis
Sequences ranged from 365 to 506 bp (median 413), and 
had an elevated average GC concentration of 36% com-
pared with the genome-wide average of around 19% [44]. 
BLAST results revealed that 39 of the 583 sequences (7%) 
were perfect matches to previously identified var2csa 
accessions in the NCBI database, and the remaining 544 
sequences had an average similarity of 87% to their top 
BLAST hit. After combining our sequences with collec-
tions from Benin and Senegal downloaded from NCBI, 
and carrying out multiple sequence alignment as detailed 
above, three highly variable regions were clearly visible 
amid four regions with zero gaps (Fig.  2). Subsequent 
analyses focused exclusively on these zero-gap regions, 
trading off the additional information contained in the 
pattern of insertions and deletions between sequences 
with increased reliability of any detected polymorphisms. 
The neighbour-joining tree revealed very little phylo-
genetic signal (see Additional file 2), and corresponding 
bootstrap values revealed little confidence in the tree, 
with only 11% of clades having  >  80% confidence. Taji-
ma’s D was estimated at 1.95, indicating that the allele 
frequencies of variants are more evenly distributed than 
expected (fewer variants at high frequency). The Z-test 
for selection revealed an excess of synonymous muta-
tions (dN–dS = − 1.445), although this was non-signif-
icant at the 5% threshold (p = 0.151).
Spatial and epidemiological analyses
After grouping sequence variants into the 115 DHS clus-
ters from which they originated, there was a median 7 
variants per cluster (range 1–28). Variants that were pre-
sent in many clusters also tended to have high BLAST 
scores (see Additional file  3), and this correlation was 
significant (ρ  =  0.176, p  <  0.001). The most common 
variant in the DRC was a 100% match to a variant pre-
viously identified from Senegal [31]. Heterozygosity was 
high both within DHS clusters (mean = 0.62, sd = 0.21) 
and between clusters (mean = 0.81, sd = 0.07), and pair-
wise  GST was also high (mean = 0.25, sd = 0.13). How-
ever, regression of genetic distance against geographic 
distance revealed no simple signal of isolation by distance 
(see Additional file 4), and the relationship was non-sig-
nificant (p = 0.217). Analysis in MAPI also showed rela-
tively uniform connectivity between clusters spanning 
the DRC, with no major barriers to gene flow and just 
one small area of significantly high genetic distance (i.e. 
low connectivity) in the Nord-Ubangi province, and one 
area of significantly low genetic distance (i.e. high con-
nectivity) in the Tshuapa province (Fig. 1).
In the analysis of allelic richness, GLMs with nega-
tive binomial error structures consistently yielded better 
model fits (lower AIC values) compared with the Pois-
son model, suggesting that allelic richness is over-dis-
persed within clusters. The best-fitting GLM included 
just 3 out of a potential 30 predictors, including linear 
and quadratic terms for prevalence and a linear term 
for sample size (Table  2). Neither median  Ct value per 
cluster nor the demographic parameters “province” and 
“urbanicity” were identified as important predictors 
of observed genetic variation. Overall the best-fitting 
GLM was a good fit to the data (Fig.  3, see also Addi-
tional file  5). In the separate analysis of  Ct values, the 
mixed effects model gave a better fit (AIC = 4346) than 
the simple linear model (AIC = 4389), and  Ct value was 
found to have a negative relationship with prevalence 
[coefficient = − 2.603, CI (− 4.359, − 0.846)], suggesting 
Table 2 Parameters of best-fitting GLM (Negative-bino-
mial model: AIC = 634.8, compared with Poisson model: 
AIC = 662.1)
Significance codes: ** < 0.01, * < 0.1
Predictor Estimate Std. error Z value p value
Intercept − 3.682 2.643 − 1.393 0.164
Prevalence 27.063 8.905 3.039 0.002**
Sample size 0.232 0.093 2.485 0.013*
Prevalence2 − 18.229 8.694 − 2.097 0.036*
Fig. 3 Observed and model-predicted relationship between preva-
lence and allelic richness. Black circles represent data for each of the 
115 clusters. Red shaded regions indicate the 95, 80 and 50% predic-
tive intervals of the best-fitting model, and the red line represents the 
median prediction. The best fitting model also includes a sample size 
term, and so these predictions were generated assuming a sample 
size of 14 (the median sample size in the data)
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that higher quantities of DNA tend to occur in samples 
obtained from high prevalence clusters.
Discussion
In recent years, a great deal of effort has gone into study-
ing the VAR2CSA protein, both in terms of its immune 
profile and its impact on clinical outcomes. However, 
while good data exists on levels of var2csa sequence 
polymorphism in several countries spanning four conti-
nents [15], to date no study has explored variation at this 
locus in samples obtained from DRC. More generally, 
understanding of the basic epidemiology and population 
genetics of this large and diverse country has been lim-
ited historically by a lack of good quality data. This study 
aimed to address this issue by quantifying var2csa varia-
tion in DRC and relating it back to basic epidemiological 
questions.
The results of this study demonstrate that var2csa is 
highly diverse within DRC, with 583 sequence variants 
identified among 812 children. High Tajima’s D and an 
excess of synonymous mutations suggest that this high 
diversity is being maintained by long-term balancing 
selection, as would be expected of a gene involved in 
antigenic variation, and as found in previous VAR2CSA 
studies [13–16]. However, there was no clear signal of 
phylogenetic structure to this diversity. Low bootstrap 
values in the neighbour joining tree indicate that differ-
ent loci provide contradictory information about the 
position of sequences in the phylogeny, suggesting that 
recombination is acting to intertwine the phylogenetic 
branches and break down patterns across loci (see Addi-
tional file 2). In the spatial analysis, there was high het-
erozygosity within and between clusters but no signal of 
increasing genetic distance with geographic distance or 
other barriers to gene flow. Together these results indi-
cate that the combined effects of rapid diversification 
through balancing selection, gene flow between spatial 
clusters, and recombination within the gene are acting 
to break down any clear signal of geographic population 
structure in this particular sub-region of var2csa. This 
contrasts with the result of Doritchamou et al. [16], who 
found clear signal of population structure in the N-ter-
minal subregion just a few hundred bp upstream of the 
target region used here, in samples taken from Benin. 
However, when the Doritchamou et al. [16] sequences are 
truncated to the same target region used here, there is no 
clear signal of population structure (results not shown). 
Therefore, it appears that the extent of var2csa phyloge-
netic signal varies greatly even within narrow sub-regions 
of this highly diverse gene. It is not clear from this study 
what impact this diversity has on acquired immunity, 
however the excess of synonymous mutations suggests 
some role in diversification of the VAR2CSA antigen.
Results of general linear modelling demonstrate that 
var2csa diversity is directly related to epidemiologi-
cal factors. The best-fitting model found that the allelic 
richness of a cluster tends to increase with prevalence, 
eventually plateauing out at high prevalence. Crucially, 
this analysis takes sampling effort into account—that is, 
prevalence is an important predictor of allelic richness 
even after accounting for the absolute number of infected 
children in the analysis. This result is in line with a wider 
body of evidence showing that genetic diversity tends to 
be higher in areas of intense transmission, perhaps due 
to increased opportunity for recombination [45–47]. 
In terms of vaccine design, this may indicate that a vac-
cine would be more likely to succeed in areas of low 
transmission where populations tend to be more clonal. 
The finding that common alleles in DRC also tend to be 
represented in other African countries (see Additional 
file 3) is also encouraging for vaccine development, as it 
indicates that some variants are common over large geo-
graphic scales, despite the general trend of strong local 
diversification.
One strength of this study is the use of samples derived 
from the DHS, which is both cross-sectional and nation-
ally representative. This ensures that asymptomatic and 
low-density (i.e. sub-microscopic) infections are captured 
in the analysis, which may include a different subset of 
strains to those found in clinically ill individuals [48]. 
A caveat is that samples were extracted from children 
under 5  years of age, and not from infected pregnant 
women, and so the pool of strains sampled here may not 
perfectly reflect those implicated in clinical disease. The 
use of pooled samples also makes it possible to explore 
a wide geographic area, and to answer questions about 
spatial connectivity (Fig. 1). However, the use of pooled 
samples also limits analysis to making observations at the 
cluster level, and cannot reliably determine factors such 
as the complexity of infection of each individual within a 
cluster.
The results of this study highlight the extreme evolu-
tionary pressures acting at the var2csa locus to promote 
antigenic variability in the DRC. This variability creates 
a substantial hurdle in the development of VAR2CSA-
based vaccine, which is extenuated by the highly-con-
nected population structure found within the DRC. A 
broad multivalent VAR2CSA vaccine candidate could 
thus benefit from targeting stable regions and common 
variants to address the substantial genetic diversity [49].
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